BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 27113721)

  • 1. Tenosynovial giant cell tumors in unusual locations detected by positron emission tomography imaging confused with malignant tumors: report of two cases.
    Takeuchi A; Yamamoto N; Hayashi K; Miwa S; Takahira M; Fukui K; Oikawa T; Tsuchiya H
    BMC Musculoskelet Disord; 2016 Apr; 17():180. PubMed ID: 27113721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.
    Brahmi M; Thiesse P; Ranchere D; Mognetti T; Pinson S; Renard C; Decouvelaere AV; Blay JY; Combemale P
    PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
    Salamon J; Mautner VF; Adam G; Derlin T
    Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of soft-tissue lesions with (18)F-FDG PET/CT: initial results of a prospective trial.
    Leal AL; Etchebehere M; Santos AO; Kalaf G; Pacheco EB; Amstalden EM; Etchebehere EC
    Nucl Med Commun; 2014 Mar; 35(3):252-9. PubMed ID: 24300379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between F-18 FDG PET/CT and pathological findings in soft tissue lesions.
    Nose H; Otsuka H; Otomi Y; Terazawa K; Takao S; Iwamoto S; Harada M
    J Med Invest; 2013; 60(3-4):184-90. PubMed ID: 24190034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Missed causative tumors in diagnosing tumor-induced osteomalacia with (18)F-FDG PET/CT: a potential pitfall of standard-field imaging.
    Kaneuchi Y; Hakozaki M; Yamada H; Hasegawa O; Tajino T; Konno S
    Hell J Nucl Med; 2016; 19(1):46-8. PubMed ID: 26929940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve-Adherent Giant Cell Tumors of Tendon Sheath: A New Presentation.
    Elsherif MA; Wenger DE; Vaubel RA; Spinner RJ
    World Neurosurg; 2016 Aug; 92():583.e19-583.e24. PubMed ID: 27250772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.
    Shin DS; Shon OJ; Han DS; Choi JH; Chun KA; Cho IH
    Ann Nucl Med; 2008 Aug; 22(7):603-9. PubMed ID: 18756363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of 18F-FDG PET/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
    Derlin T; Tornquist K; Münster S; Apostolova I; Hagel C; Friedrich RE; Wedegärtner U; Mautner VF
    Clin Nucl Med; 2013 Jan; 38(1):e19-25. PubMed ID: 23242059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodality imaging of an unusual giant cell tumor of thoracic spine with mediastinal invasion: a case report.
    Huang W; Peng Y; Zhang Y; Chao F; Li L; Qiu Y; Gao J; Kang L
    Am J Nucl Med Mol Imaging; 2023; 13(6):289-294. PubMed ID: 38204605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of diffuse tenosynovial giant cell tumor arising from temporomandibular joints].
    Meng JH; Guo YX; Luo HY; Guo CB; Ma XC
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1049-1054. PubMed ID: 27987512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
    Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
    Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG-PET for preoperative differential diagnosis between benign and malignant soft tissue masses.
    Aoki J; Watanabe H; Shinozaki T; Takagishi K; Tokunaga M; Koyama Y; Sato N; Endo K
    Skeletal Radiol; 2003 Mar; 32(3):133-8. PubMed ID: 12605276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1.
    Karabatsou K; Kiehl TR; Wilson DM; Hendler A; Guha A
    Neurosurgery; 2009 Oct; 65(4 Suppl):A160-70. PubMed ID: 19927062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
    Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
    Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using ¹⁸F-FDG positron emission tomography: a retrospective cohort study.
    Yanagawa T; Saito K; Kiyohara H; Ohno T; Nakano T; Takagishi K
    Radiat Oncol; 2015 Dec; 10():259. PubMed ID: 26691334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False-negative fluorine-18 fluorodeoxyglucose positron emission tomography of a malignant peripheral nerve sheath tumor arising from a plexiform neurofibroma in the setting of neurofibromatosis type 1.
    Shahid KR; Amrami KK; Esther RJ; Lowe VJ; Spinner RJ
    J Surg Orthop Adv; 2011; 20(2):132-5. PubMed ID: 21838076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
    Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
    J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenosynovial giant cell tumors of the temporomandibular joint and lateral skull base: Review of 11 cases.
    Carlson ML; Osetinsky LM; Alon EE; Inwards CY; Lane JI; Moore EJ
    Laryngoscope; 2017 Oct; 127(10):2340-2346. PubMed ID: 27888510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
    Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
    Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.